Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Dec;76(6):1560-1562.
doi: 10.1002/hep.32668. Epub 2022 Jul 26.

COVID-19-associated cholangiopathy: What is left after the virus has gone?

Niklas Heucke  1 , Verena Keitel
Affiliations
Editorial

COVID-19-associated cholangiopathy: What is left after the virus has gone?

Niklas Heucke et al. Hepatology. 2022 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Verena Keitel advises AstraZeneca and is on the speakers’ bureau for Albireo, Falk, AbbVie, Gilead, CSL Behring, and Intercept.

Comment on

References

    1. Hartl L, Haslinger K, Angerer M, Semmler G, Schneeweiss‐Gleixner M, Jachs M, et al. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in chronic liver disease patients. Hepatology. 2022. May 21. 10.1002/hep.32582. [Epub ahead of print] - DOI - PMC - PubMed
    1. Dufour JF, Marjot T, Becchetti C, Tilg H. COVID‐19 and liver disease. Gut. 2022. Jun 14. 10.1136/gutjnl-2021-326792. [Epub ahead of print] - DOI - PubMed
    1. Klindt C, Jensen BE, Brandenburger T, Feldt T, Killer A, Schimmöller L, et al. Secondary sclerosing cholangitis as a complication of severe COVID‐19: a case report and review of the literature. Clin Case Rep. 2021;9:e04068. - PMC - PubMed
    1. Bütikofer S, Lenggenhager D, Wendel Garcia PD, Maggio EM, Haberecker M, Reiner CS, et al. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID‐19. Liver Int. 2021;41:2404–17. - PMC - PubMed
    1. Lui VC‐H, Hui KP‐Y, Babu RO, Yue H, Chung PH‐Y, Tam PK‐H, et al. Human liver organoid derived intra‐hepatic bile duct cells support SARS‐CoV‐2 infection and replication. Sci Rep. 2022;12:5375. - PMC - PubMed